214 related articles for article (PubMed ID: 20963568)
1. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Álvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
Endocrine; 2010 Feb; 37(1):180-6. PubMed ID: 20963568
[TBL] [Abstract][Full Text] [Related]
2. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Alvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
Endocrine; 2010 Apr; 37(2):322-8. PubMed ID: 20960270
[TBL] [Abstract][Full Text] [Related]
3. Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis.
Giner M; Rios MJ; Montoya MJ; Vázquez MA; Miranda C; Pérez-Cano R
Eur J Pharmacol; 2011 Jan; 650(2-3):682-7. PubMed ID: 21050847
[TBL] [Abstract][Full Text] [Related]
4. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.
Lee JW; Iwahashi A; Hasegawa S; Yonezawa T; Jeon WB; Cha BY; Nagai K; Woo JT
J Nat Med; 2012 Jan; 66(1):8-16. PubMed ID: 21656335
[TBL] [Abstract][Full Text] [Related]
5. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts].
Dong W; Qi M; Deng J; Chen H; Feng X; Liao N
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1695-8. PubMed ID: 23268391
[TBL] [Abstract][Full Text] [Related]
6. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
7. 99Tc-MDP-induced human osteoblast proliferation, differentiation and expression of osteoprotegerin.
Chen J; Lan Y; He Y; He C; Xu F; Zhang Y; Zhao Y; Liu Y
Mol Med Rep; 2017 Aug; 16(2):1801-1809. PubMed ID: 28656306
[TBL] [Abstract][Full Text] [Related]
8. Differences in otosclerotic and normal human stapedial osteoblast properties are normalized by alendronate in vitro.
Gronowicz G; Richardson YL; Flynn J; Kveton J; Eisen M; Leonard G; Aronow M; Rodner C; Parham K
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):657-66. PubMed ID: 25085325
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
[TBL] [Abstract][Full Text] [Related]
11. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
[TBL] [Abstract][Full Text] [Related]
12. Alendronate stimulates osteoprotegerin expression in fibroblasts from periprosthetic membrane.
Qian Y; Zhang XL; Jiang Y; Zeng BF; Wang Q; Chen Y; Shen H; Wang Q
Hip Int; 2015; 25(6):581-4. PubMed ID: 26351115
[TBL] [Abstract][Full Text] [Related]
13. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis.
Giner M; Rios MA; Montoya MA; Vázquez MA; Naji L; Pérez-Cano R
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):46-51. PubMed ID: 19073256
[TBL] [Abstract][Full Text] [Related]
14. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects.
Corrado A; Neve A; Macchiarola A; Gaudio A; Marucci A; Cantatore FP
J Rheumatol; 2013 May; 40(5):684-94. PubMed ID: 23457386
[TBL] [Abstract][Full Text] [Related]
15. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
Koch FP; Merkel C; Ziebart T; Smeets R; Walter C; Al-Nawas B
Clin Oral Investig; 2012 Feb; 16(1):79-86. PubMed ID: 20938793
[TBL] [Abstract][Full Text] [Related]
16. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
[TBL] [Abstract][Full Text] [Related]
17. Prolactin decreases the expression ratio of receptor activator of nuclear factor kappaB ligand/osteoprotegerin in human fetal osteoblast cells.
Seriwatanachai D; Charoenphandhu N; Suthiphongchai T; Krishnamra N
Cell Biol Int; 2008 Sep; 32(9):1126-35. PubMed ID: 18556224
[TBL] [Abstract][Full Text] [Related]
18. Alendronate induces mineralization in mouse osteoblastic MC3T3-E1 cells: regulation of mineralization-related genes.
Inoue Y; Hisa I; Seino S; Kaji H
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):719-23. PubMed ID: 20213600
[TBL] [Abstract][Full Text] [Related]
19. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.
Tat SK; Pelletier JP; Vergés J; Lajeunesse D; Montell E; Fahmi H; Lavigne M; Martel-Pelletier J
Arthritis Res Ther; 2007; 9(6):R117. PubMed ID: 17996099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
